MarketBeat
14 May 2026, 04:14 UTC · 18w ago
Verdict
Headline takes no side. We score TMO +0.20 across five claims — slightly bullish.
+0.20slightly bullish
More positive than 51% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Seer reaffirmed its full-year 2026 revenue guidance of $16 million to $18 million, representing roughly 3% growth at the midpoint despite a weak first quarter.
So whatMaintaining annual guidance despite a severe Q1 miss signals management confidence in a second-half recovery, preventing an immediate downward revision in forward estimates.
More positive than 97% of claims this week
Seer's Q1 total revenue fell to $2.8 million from $4.2 million year-over-year, with gross margin dropping to 35% from 49% due to lower absorption of fixed costs.
A 33% revenue decline and massive gross margin contraction reflect severe current demand weakness and operating deleverage, creating significant near-term fundamental pressure.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 98% of claims this week
Management cited a depressed academic funding environment and increased competitive activity from inferior product imitators as primary headwinds pressuring customer budgets.
So whatStructural headwinds in the core academic market and emerging competition threaten market share and pricing power, introducing uncertainty regarding the sustainability of future revenue.
More negative than 91% of claims this week
Seer filed a patent infringement lawsuit against Nanomics Biotechnology after the Patent Trial and Appeal Board upheld 23 of 29 claims in a key nanoparticle patent.
More positive than 77% of claims this week
Seer ended the quarter with $219.5 million in cash, which management believes is sufficient to reach cash flow breakeven.
So whatA strong cash position against a $15.7 million quarterly cash burn significantly reduces near-term dilution and financing risks, providing operational runway.
More positive than 70% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
38m ago
+47.8%
Price agrees with the score
$659.37 vs $446.03 close before publication (May 13) · not market-adjusted
TMO chart →
